Pfizer says coronavirus vaccine is 90 percent effective in clinical tests

U.S. pharmaceutical giant Pfizer says clinical tests of its new coronavirus vaccine have proved to be 90 percent effective. But it will still be several months, or even longer before the vaccine becomes widely available. Ted Chernecki reports

• EU to secure up to 300 million doses of Pfizer-BioNTech coronavirus vaccine: commission
• Vancouver-based biotech company central in development of Pfizer COVID-19 vaccine